Pieris Pharmaceuticals Inc
NASDAQ:PIRS

Watchlist Manager
Pieris Pharmaceuticals Inc Logo
Pieris Pharmaceuticals Inc
NASDAQ:PIRS
Watchlist
Price: 12.0296 USD -27.16% Market Closed
Market Cap: 100.1m USD

Wall Street
Price Targets

PIRS Price Targets Summary
Pieris Pharmaceuticals Inc

There are no price targets for PIRS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pieris Pharmaceuticals Inc Competitors:
Price Targets
ALGEN
Genoway SA
88% Upside
MRNA
Moderna Inc
57% Upside
ALKS
Alkermes Plc
44% Upside
GLPG
Galapagos NV
23% Upside
251120
Bio-FD&C Co Ltd
2% Upside
6855
Ascentage Pharma Group International
31% Downside
ARMP
Armata Pharmaceuticals Inc
323% Upside
IMAB
I-Mab
156% Upside

Revenue
Forecast

Revenue Estimate
Pieris Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Pieris Pharmaceuticals Inc's revenue is 40%.

40%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
31%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Pieris Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Pieris Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PIRS's stock price target?
Not Available

PIRS doesn't have any price targets made by Wall Street professionals.

Back to Top